跳至主要内容
临床试验/NCT06649097
NCT06649097招募中不适用

Clearance of Intracranial Blood Products by Continuous Irrigation With the IRRAflow System

Christopher P Kellner1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2025年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250
试验地点
1
主要终点
Residual blood volume by post bleed day 5

研究概览

简要总结

The study is a multi-center prospective cohort, controlled, phase 4 post-market registry evaluating the efficacy and radiographic outcomes associated with the use of the IRRAflow® Active Fluid Exchange System compared to standard of care external ventricular drains.

详细描述

The IRRAflow system offers automated irrigation, controlled drainage, and ICP monitoring all in one system for the treatment of intracranial hemorrhage - [Intracerebral hemorrhage (ICH), Intraventricular hemorrhage (IVH), Subarachnoid hemorrhage (SAH), Subdural hematoma (SDH)], intracranial abscess, and ventriculitis.

The analysis of the IRRAS catheter will occur prospectively if it is determined the patient meets the enrollment criteria. All patients enrolled in the trial will receive additional supportive and medical treatment by choice of the treating physician and in accordance with standard of care. Such treatment includes but is not limited to neurointensive care, neuromonitoring, and surgical or endovascular occlusion of identified sources of intracranial hemorrhage (e.g. vascular anomalies, aneurysms, etc.).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Residual blood volume by post bleed day 5

时间窗: Post-procedure day 5

The residual blood volume at day 5 will be calculated to determine the efficacy of the IRRAflow system compared to other external ventricular drains (EVDs)

Utility weighted modified Rankin Score

时间窗: End of study, at 6 months

Modified Rankin Scale score at 6 months will be collected to determine patient functional outcomes at 6 months. Scores range from 0 to 6, with 0 indicating no disability and 6 indicating death

次要结局

  • Rate of blood clearance(Immediately before and after the procedure)
  • Direct hospitalization costs(Discharge, up to 7 days post procedure)
  • NSICU Length of Stay(Discharge, up to 7 days post procedure)
  • Hospital Length of Stay (LOS)(Discharge, up to 7 days post procedure)
  • Proportion of participants needing a shunt(Discharge, up to 7 days post procedure)

研究者

发起方
Christopher P Kellner
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Christopher P Kellner

Associate Professor, Neurosurgery

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验

Clearance of Intracranial Blood Products by... | 临床试验